Carlo Bartoli, MD, PhD is a cardiac surgeon-scientist with special interests in surgical management of congenital and acquired heart disease, development and clinical implantation of mechanical circulatory support devices, von Willebrand factor biology, and angiogenesis.

Dr. Bartoli attended Cornell University, Harvard University, and the University of Louisville School of Medicine (combined MD/PhD pathway).  He completed integrated cardiothoracic surgery residency at the Hospital of the University of Pennsylvania and pediatric cardiac surgery fellowship at the Children’s Hospital of Philadelphia.  Dr. Bartoli cares for patients of all ages from the neonate to the child to the adult.  

In parallel with his clinical practice, Dr. Bartoli manages an internationally-recognized translational biophysics laboratory that is independently funded with support from the NIH, multiple congenital cardiology foundations, and industry partners.  Ongoing projects examine mechanical circulatory support in the fetus to the adult and include left ventricular assist device (LVAD) design and development, mechanisms of LVAD-associated bleeding and thrombosis, novel LVAD therapies, abnormal angiogenesis in children with single ventricle disease, and cardiovascular biology of the placenta.  Advancing the field of cardiovascular medicine and training MD/PhD physician-scientists are major goals of the laboratory.

Dr. Bartoli has won numerous national and international scientific awards that include the 2020 American College of Cardiology Doug Zipes Distinguished Investigator Award “for contributions to cardiovascular medicine and significant body of work”, the Pennsylvania Medical Society 40 Under 40 Physicians Award, and awards from the Society of Thoracic Surgeons, International Society of Mechanical Circulatory Support, and American College of Cardiology.  Dr. Bartoli sits on the Board of Directors for the International Society of Mechanical Circulatory Support and Medical Advisory Boards for Abiomed Inc, Evaheart International Inc, and Windmill Cardiovascular Systems Inc.  He has published more than 70 peer-reviewed articles in biomedical journals and given more than 65 talks at international locations.